Table 2 BMD measurements based on spectral CT compared to a phantom containing four known concentrations of calcium hydroxyapatite (HA) (100, 200, 400, and 800 mg/cm3).

From: Bone mineral density measurements in vertebral specimens and phantoms using dual-layer spectral computed tomography

Measurement differences:

Phantom HA concentrations:

800 mg/cm3

400 mg/cm3

200 mg/cm3

100 mg/cm3

mg/cm3

%

mg/cm3

%

mg/cm3

%

mg/cm3

%

Exposure:

1000 mAs

+1.2

+0.15%

−2.3

−0.56%

−1.5

−0.71%

+2.6

+2.58%

500 mAs

−0.3

−0.03%

−3.5

−0.87%

−1.3

−0.61%

+3.5

+3.49%

250 mAs

+1.5

+0.19%

−3.2

−0.79%

−2.6

−1.26%

+3.0

+2.99%

125 mAs

+13.2

+1.63%

+2.0

+0.51%

+3.1

+1.49%

+4.8

+4.79%

50 mAs

+43.0

+5.32%

+24.2

+5.98%

+13.8

+6.62%

+11.2

+11.22%

38 mAs

+53.1

+6.56%

+26.7

+6.58%

+18.4

+8.83%

+14.8

+14.84%

  1. Positive differences indicate higher BMD measurement values compared to known HA densities as specified by the phantom manufacturer.